Dr. Jacalyn Rosenblatt received her M.D. at McGill University School of Medicine in 1997. She completed her internal medicine residency training at McGill University Health Center and fellowship in Hematology/Oncology at Beth Israel Deaconess Medical Center. Dr. Rosenblatt joined the attending staff of Hematology/Oncology at Beth Israel Deaconess Medical Center in 2003, and is an Associate Professor of Medicine at Harvard Medical School. She is the Associate Chief in the Division of Hematology and Hematologic Malignancies. Dr. Rosenblatt`s research has focused in a translational research program for immunotherapy for hematological malignancies. She leads the multiple myeloma program at BIDMC, is co-director of the cancer vaccine and cellular immunotherapy program, and is medical director of the Cellular Immunotherapy Cell Manipulation Facility at BIDMC.